USCA RIA’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$1.95M Sell
16,715
-1,108
-6% -$133K 0.12% 222
2021
Q1
$1.96M Buy
17,823
+6,914
+63% +$751K 0.13% 212
2020
Q4
$1.09M Buy
+10,909
New +$1.01M 0.08% 229
2020
Q2
Sell
-4,678
Closed -$218K 457
2020
Q1
$218K Buy
4,678
+155
+3% +$9.95K 0.03% 359
2019
Q4
$358K Buy
+4,523
New +$348K 0.03% 374
2019
Q2
Sell
-34,900
Closed -$2.65M 455
2019
Q1
$2.65M Buy
34,900
+26,159
+299% +$2.08M 0.29% 118
2018
Q4
$639K Sell
8,741
-8,998
-51% -$717K 0.09% 234
2018
Q3
$1.7M Buy
17,739
+3,693
+26% +$366K 0.17% 164
2018
Q2
$1.4M Buy
+14,046
New +$1.48M 0.15% 182
2016
Q1
Sell
-20,323
Closed -$1.37M 365
2015
Q4
$1.37M Buy
20,323
+4,999
+33% +$350K 0.3% 101
2015
Q3
$992K Buy
15,324
+422
+3% +$31.2K 0.25% 121
2015
Q2
$1.22M Buy
+14,902
New +$1.15M 0.32% 86
2014
Q2
Sell
-9,686
Closed -$835K 293
2014
Q1
$835K Buy
9,686
+1,161
+14% +$95.2K 0.3% 106
2013
Q4
$688K Buy
+8,525
New +$662K 0.27% 114

Other funds holding EMN

USCA RIA's EMN Position: Q2 2021 in Review

USCA RIA reduced its Eastman Chemical (EMN) stake by 6.2% in Q2 2021, selling an estimated $133K and leaving 16,715 shares worth $1.95M. The position accounts for 0.12% of the portfolio, ranked #222.

USCA RIA first reported a position in EMN in Q4 2013 and has held it in 14 quarters since. The position peaked at $2.65M in Q1 2019. 723 funds tracked by Wall St. Rank hold EMN as of Q2 2021.

  • USCA RIA held 16,715 shares of Eastman Chemical worth $1.95M as of Q2 2021.
  • USCA RIA sold 1,108 Eastman Chemical shares in Q2 2021, an estimated $133K.
  • Eastman Chemical made up 0.12% of USCA RIA's portfolio in Q2 2021, its #222 holding.
  • USCA RIA first reported a position in Eastman Chemical in Q4 2013 and has held it in 14 quarters since.
  • USCA RIA's Eastman Chemical position peaked at $2.65M in Q1 2019.
  • 723 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.